OptMed Overview

  • Founded
  • 2007
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

OptMed General Information

Description

Developer of a biocompatible polymer and genitourinary therapeutic platform designed to treat lower urinary tract infections. The company's biocompatible polymer and genitourinary therapeutic platform offers investigation devices that combines proprietary polymer and advanced delivery technology, enabling doctors to treat lower urinary tract conditions, including overactive bladder and kidney stones.

Contact Information

Website
www.optmed.net
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly Angel backed
Primary Industry
Other Devices and Supplies
Other Industries
Social/Platform Software
Biotechnology
Parent Company
Jiangsu Xinlikang Medical Technology
Primary Office
  • 745 Fifth Avenue
  • Suite 500
  • New York, NY 10151
  • United States
+1 (212) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

OptMed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 06-Sep-2017 000.00 Completed Generating Revenue
7. Angel (individual) 11-Aug-2015 00.00 000.00 Completed Generating Revenue
6. Angel (individual) 27-Jun-2014 0000 00.00 Completed Generating Revenue
5. Angel (individual) 11-Jun-2013 00000 00.00 Completed Generating Revenue
4. Angel (individual) 21-Aug-2012 00000 00.00 Completed Generating Revenue
3. Angel (individual) 29-Apr-2011 00000 00.00 Completed Generating Revenue
2. Angel (individual) 28-Apr-2011 $6M $8M Completed Generating Revenue
1. Angel (individual) 01-Sep-2009 $2M $2M Completed Generating Revenue
To view OptMed’s complete valuation and funding history, request access »

OptMed Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a biocompatible polymer and genitourinary therapeutic platform designed to treat lower urinary tract infect
Other Devices and Supplies
New York, NY
000.00
000000&0 000.00

00 00000

tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitati
00000000 0000000
Dublin, Ireland
000 As of 0000
00000
0000000000 0 00000

00000000

dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur si
000000000000000
Vancouver, Canada
000 As of 0000
000.00
000 0000-00-00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OptMed Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GC Aesthetics Venture Capital-Backed Dublin, Ireland 000 00000 0000000000 0 00000
00000000 000000 Formerly VC-backed Vancouver, Canada 000 000.00 000000&0 000.00
00000 0000000 Venture Capital-Backed Dallas, TX 00 0000 0000000000 0 0000
000000000 Formerly VC-backed South San Francisco, CA 00000 000.00 00000000000
To view OptMed’s complete competitors history, request access »

OptMed Executive Team (2)

Name Title Board Seat Contact Info
Ervin Braun MD Co-Chief Executive Officer & Board Member
Alain Klapholz Co-Founder, Board Member, Co-Chief Executive Officer & Chief Operating Officer
To view OptMed’s complete executive team members history, request access »

OptMed Board Members (6)

Name Representing Role Since
Alain Klapholz OptMed Co-Founder, Board Member, Co-Chief Executive Officer & Chief Operating Officer 000 0000
Ervin Braun MD OptMed Co-Chief Executive Officer & Board Member 000 0000
Kevin Mckim Self Board Member 000 0000
Martin Sands Self Co-Chairman 000 0000
Sanket Parekh Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »